MedTrace Logo

Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

NCT07670897 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-06-26

No results posted yet for this study

Summary

This study is a single-center, open-label, randomized, single-dose bioequivalence trial conducted in healthy adult participants.

Conditions

Interventions

DRUG

GZR4 injection A

GZR4 s.c., single-dose

DRUG

GZR4 injection B

GZR4 s.c., single-dose

Sponsors & Collaborators

  • Gan & Lee Pharmaceuticals.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-07-29
Completion
2026-07-29

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07670897 on ClinicalTrials.gov